Patient and Staff Safety During Aorto-iliac Revascularization Procedures Under Automated Fusion Imaging Guidance With Controls
- Conditions
- Patient and Staff Radiation Exposure During Aorto-iliac Endovascular Revascularization
- Interventions
- Device: Control with imaging guidanceDevice: Control without imaging guidance
- Registration Number
- NCT03713450
- Lead Sponsor
- Nantes University Hospital
- Brief Summary
Endovascular revascularization has revolutionized the field of vascular surgery and has become the first-choice treatment for peripheral arteries occlusive disease. However, the drawback of this technic is the X-ray exposure for both patients and staff and the iodinated contrast injection for the patient.
One way to reduce both radiation and contrast use is to use advanced imaging techniques allowing an overlay of a 3D vascular mask (from a pre-operative CT scan) onto the live X-ray image. This has been proven during endovascular aneurysm repair.
This advanced imaging application is currently available only in the latest expensive hybrid operating rooms, requires additional manoeuvre from the operator throughout the procedure, and may be X-rays and contrast consuming.
This trial will examine the clinical benefits based on patient and staff' radiation exposure during aorto-iliac revascularisation, of a new software imaging guidance, suitable for any theatre including those equipped with mobile C-arm, fully automated and with a radiation free overlay registration process.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 45
- Male or female aged 18 or older,
- Patients scheduled for aorto iliac endovascular revascularisation,
- Pre-operative CT scan.
- Women of childbearing age,
- Absence of preoperative CT scan,
- Emergency procedures.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control with imaging guidance Control with imaging guidance - Control without imaging guidance Control without imaging guidance -
- Primary Outcome Measures
Name Time Method Dose area product The end of the procedure Dose area product (DAP) by the end of the procedure.
- Secondary Outcome Measures
Name Time Method Number of DSA runs The end of the procedure Number of DSA runs by the end of the procedure.
Contrast volume The end of the procedure Contrast volume (ml) by the end of the procedure.
Operative time The end of the procedure Operative time (min) by the end of the procedure.
Operator exposure The end of the procedure Operator exposure (Sv) by the end of the procedure.
Air Kerma The end of the procedure Air Kerma (mGy) by the end of the procedure.
Fluoroscopy time The end of the procedure Fluoroscopy time (min) by the end of the procedure.
Trial Locations
- Locations (1)
Nantes University Hospital, Vascular surgery, Institut du Thorax
🇫🇷Nantes, France